Source: ERS Lung Science Conference 2021



Rating:

Share or cite this content

Citations should be made in the following way:
Georgia A. Giotopoulou, Germany. PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Causal RNA signatures in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009 Comparative gene expression analysis in lung cancer Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Analysis of circular RNAs expression profile in pleural metastases from lung adenocarcinoma Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Differential expression analysis of lncRNA in different types of lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Proteomic analysis of human small cell lung cancer tissues Source: Annual Congress 2009 - Lung cancer biology Year: 2009 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Mutational status of advanced lung adenocarcinoma in a Portuguese cohort Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Source: Eur Respir J 2014; 43: 1740-1749 Year: 2014 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Epigenetic inactivation of checkpoint kinase 2 gene in nonsmall cell lung cancer and its relationship with clinicopathological features Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007 Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005